PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.\', \'Norwegian Institute of Public Health, Oslo, Norway.\', \'Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.\', \'Clinical Effectiveness Research Group, Oslo University Hospital, Oslo, Norway.\', \'Clinical Effectiveness Research Group, University of Oslo, Oslo, Norway.\', \'Department of Immunology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2807/1560-7917.ES.2022.27.13.2100376
?:hasPublicationType
?:journal
  • Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
is ?:pmid of
?:pmid
?:pmid
  • 35362405
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Seroprevalence of antibodies against SARS-CoV-2 in the adult population during the pre-vaccination period, Norway, winter 2020/21.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35362405>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35362405>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all